Market News

Growth is a hallmark of all great companies, but the laws of gravity eventually take hold. Those who rode the COVID boom and ensuing tech selloff in 2...

Escalade Q3 2026 EPS beat estimates but revenue missed, sending ESCA shares lower pre-market as investors focus on sales momentum.

Genmab stock surged on strong Phase 3 cancer data, but valuation and patent risks remain. Click here to read this recent analysis of GMAB stock.

Enterprise Products Q3 2026 results: EPS in line, revenue beats estimates, record volumes and strong cash flow, but market reaction stays muted.

Eli Lilly and Company remains a Buy, as its Q3 results show strong revenue growth and rising Mounjaro and Zepbound sales. Click for a detailed LLY upd...

Entegris Q3 2026 earnings beat estimates: revenue $1.01B, EPS $1.23; strong Q4 guidance above consensus, stock up 5.5% premarket on margin gains.

Investing.com -- SAP shares fell nearly 2% in premarket trading Thursday following disappointing results from software peers ServiceNow and Fortinet, ...

Tesla's electric vehicle business just took another step backwards.

Bath & Body Works is benefiting from strong international demand, higher product shipments and store expansion as it works to restore sustainable grow...

COP gears up for Q3 earnings with higher oil prices, strong profit and revenue growth estimates, and positive indicators pointing to a potential beat.

D.R. Horton, Inc.

Aerospace and defense company Huntington Ingalls (NYSE:HII) reported revenue ahead of Wall Street’s expectations in Q3 2026, with revenue rising 10.8%...

The Federal Reserve has hit the pause button on interest rates. While the Fed stands still, should you start moving? Allspring Global Investments seni...

EMCOR Q3 revenue and EPS beat consensus, full-year guidance raised on record RPO, lifting shares premarket after a recent pullback.

Leonardo DRS Q3 2026 earnings beat estimates on revenue and adjusted EPS; record $5.6B backlog and raised outlook lifted shares 4.76% premarket.

For questions about this article or underlying research, email [email protected].

For questions about this article or underlying research, email [email protected].

For questions about this article or underlying research, email [email protected].

Tenable stock looks undervalued given strong cybersecurity demand, accelerating revenue growth, and lower valuation vs. peers. Learn more about TENB s...

Eli Lilly blew past sales expectations Thursday and hiked its outlook on the back of strong performance from Mounjaro and Zepbound.